Expression of UME6, a key regulator of Candida albicans hyphal development, enhances biofilm formation via Hgc1- and Sun41- dependent mechanisms

Eukaryotic Cell

Volumn 12, Issue 2, 2013, Pages 224-232

  Banerjee, Mohua ^a   Uppuluri, Priya ^b   Zhao, Xiang R ^c   Carlisle, Patricia L ^a   Vipulanandan, Geethanjali ^a   Villar, Cristina C ^c   López Ribot, José L ^b   Kadosh, David ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; FUNGAL PROTEIN; GLYCOSIDASE; TRANSCRIPTION FACTOR;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL CULTURE; COCULTURE; EPITHELIUM CELL; FUNGUS HYPHAE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MICROBIOLOGY; MOUTH MUCOSA; PHYSIOLOGY; TRANSCRIPTION INITIATION;

BIOFILMS; CANDIDA ALBICANS; CELLS, CULTURED; COCULTURE TECHNIQUES; CYCLINS; EPITHELIAL CELLS; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; GLYCOSIDE HYDROLASES; HUMANS; HYPHAE; MOUTH MUCOSA; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84873152717     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00163-12     Document Type: Article

References (66)

1. Odds FC. 1988. Candida and candidosis. Baillière Tindall, London, United Kingdom.
2. Beck-Sague C, Jarvis WR. 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J. Infect. Dis. 167:1247-1251.
3. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. 1999. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis. 29:239-244.
4. Pfaller MA, Lockhart SR, Pujol C, Swails-Wenger JA, Messer SA, Edmond MB, Jones RN, Wenzel RP, Soll DR. 1998. Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates. J. Clin. Microbiol. 36:1518-1529.
5. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.
6. Cannon RD, Chaffin WL. 1999. Oral colonization by Candida albicans. Crit. Rev. Oral Biol. Med. 10:359-383.
7. Dongari-Bagtzoglou A, Wen K, Lamster IB. 1999. Candida albicans triggers interleukin-6 and interleukin-8 responses by oral fibroblasts in vitro. Oral Microbiol. Immunol. 14:364-370.
8. Dupont PF. 1995. Candida albicans, the opportunist. A cellular and molecular perspective. J. Am. Podiatr. Med. Assoc. 85:104-115.
9. Filler SG, Kullberg BJ. 2002. Deep-seated candidal infections, p 341-348. In Calderone R (ed), Candida and candidiasis. ASM Press, Washington, DC.
10. Weig M, Gross U, Muhlschlegel F. 1998. Clinical aspects and pathogenesis of Candida infection. Trends Microbiol. 6:468-470.
11. Douglas LJ. 2002. Medical importance of biofilms in Candida infections. Rev. Iberoam. Micol. 19:139-143.
12. Douglas LJ. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11:30-36.
13. Kojic EM, Darouiche RO. 2004. Candida infections of medical devices. Clin. Microbiol. Rev. 17:255-267.
14. Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL. 2005. Candida biofilms: an update. Eukaryot. Cell 4:633-638.
15. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183: 5385-5394.
16. Finkel JS, Mitchell AP. 2011. Genetic control of Candida albicans biofilm development. Nat. Rev. Microbiol. 9:109-118.
17. Lopez-Ribot JL. 2005. Candida albicans biofilms: more than filamentation. Curr. Biol. 15:R453-R455. doi:10.1016/j.cub.2005.06.020.
18. Ramage G, Vandewalle K, Wickes BL, Lopez-Ribot JL. 2001. Characteristics of biofilm formation by Candida albicans. Rev. Iberoam. Micol. 18:163-170.
19. Hoyer LL. 2001. The ALS gene family of Candida albicans. Trends Microbiol. 9:176-180.
20. Li F, Palecek SP. 2003. EAP1, a Candida albicans gene involved in binding human epithelial cells. Eukaryot. Cell 2:1266-1273.
21. Li F, Svarovsky MJ, Karlsson AJ, Wagner JP, Marchillo K, Oshel P, Andes D, Palecek SP. 2007. Eap1p, an adhesin that mediates Candida albicans biofilm formation in vitro and in vivo. Eukaryot. Cell 6:931-939.
22. Nobile CJ, Schneider HA, Nett JE, Sheppard DC, Filler SG, Andes DR, Mitchell AP. 2008. Complementary adhesin function in C. albicans biofilm formation. Curr. Biol. 18:1017-1024.
23. Staab JF, Bradway SD, Fidel PL, Sundstrom P. 1999. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 283:1535-1538.
24. Zhao X, Oh SH, Cheng G, Green CB, Nuessen JA, Yeater K, Leng RP, Brown AJ, Hoyer LL. 2004. ALS3 and ALS8 represent a single locus that encodes a Candida albicans adhesin; functional comparisons between Als3p and Als1p. Microbiology 150:2415-2428.
25. Firon A, Aubert S, Iraqui I, Guadagnini S, Goyard S, Prevost MC, Janbon G, d'Enfert C. 2007. The SUN41 and SUN42 genes are essential for cell separation in Candida albicans. Mol. Microbiol. 66:1256-1275.
26. Hiller E, Heine S, Brunner H, Rupp S. 2007. Candida albicans Sun41p, a putative glycosidase, is involved in morphogenesis, cell wall biogenesis, and biofilm formation. Eukaryot. Cell 6:2056-2065.
27. Norice CT, Smith FJ, Jr, Solis N, Filler SG, Mitchell AP. 2007. Requirement for Candida albicans Sun41 in biofilm formation and virulence. Eukaryot. Cell 6:2046-2055.
28. Ramage G, VandeWalle K, Lopez-Ribot J, Wickes B. 2002. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol. Lett. 214:95. doi:10.1111/j.1574-6968.2002.tb11330.x.
29. Uppuluri P, Pierce CG, Thomas DP, Bubeck SS, Saville SP, Lopez-Ribot JL. 2010. The transcriptional regulator Nrg1p controls Candida albicans biofilm formation and dispersion. Eukaryot. Cell 9:1531-1537.
30. Stoldt VR, Sonneborn A, Leuker CE, Ernst JF. 1997. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J. 16:1982-1991.
31. Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, Johnson AD. 2012. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148:126-138.
32. Du H, Guan G, Xie J, Sun Y, Tong Y, Zhang L, Huang G. 2012. Roles of Candida albicans Gat2, a GATA-type zinc finger transcription factor, in biofilm formation, filamentous growth and virulence. PLoS One 7:e29707. doi:10.1371/journal.pone.0029707.
33. Banerjee M, Thompson DS, Lazzell A, Carlisle PL, Pierce C, Monteagudo C, Lopez-Ribot JL, Kadosh D. 2008. UME6, a novel filamentspecific regulator of Candida albicans hyphal extension and virulence. Mol. Biol. Cell 19:1354-1365.
34. Carlisle PL, Banerjee M, Lazzell A, Monteagudo C, Lopez-Ribot JL, Kadosh D. 2009. Expression levels of a filament-specific transcriptional regulator are sufficient to determine Candida albicans morphology and virulence. Proc. Natl. Acad. Sci. U. S. A. 106:599-604.
35. Zeidler U, Lettner T, Lassnig C, Muller M, Lajko R, Hintner H, Breitenbach M, Bito A. 2009. UME6 is a crucial downstream target of other transcriptional regulators of true hyphal development in Candida albicans. FEMS Yeast Res. 9:126-142.
36. Uppuluri P, Chaturvedi AK, Srinivasan A, Banerjee M, Ramasubramaniam AK, Kohler JR, Kadosh D, Lopez-Ribot JL. 2010. Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog. 6:e1000828. doi:10.1371/journal.ppat.1000828.
37. Carlisle PL, Kadosh D. 2010. Candida albicans Ume6, a filament-specific transcriptional regulator, directs hyphal growth via a pathway involving Hgc1 cyclin-related protein. Eukaryot. Cell 9:1320-1328.
38. Gonzalez-Novo A, Correa-Bordes J, Labrador L, Sanchez M, Vazquez de Aldana CR, Jimenez J. 2008. Sep7 is essential to modify septin ring dynamics and inhibit cell separation during Candida albicans hyphal growth. Mol. Biol. Cell 19:1509-1518.
39. Park HO, Bi E. 2007. Central roles of small GTPases in the development of cell polarity in yeast and beyond. Microbiol. Mol. Biol. Rev. 71:48-96.
40. Sinha I, Wang YM, Philp R, Li CR, Yap WH, Wang Y. 2007. Cyclindependent kinases control septin phosphorylation in Candida albicans hyphal development. Dev. Cell 13:421-432.
41. Wang A, Raniga PP, Lane S, Lu Y, Liu H. 2009. Hyphal chain formation in Candida albicans: Cdc28-Hgc1 phosphorylation of Efg1 represses cell separation genes. Mol. Cell. Biol. 29:4406-4416.
42. Wang Y. 2009. CDKs and the yeast-hyphal decision. Curr. Opin. Microbiol. 12:644-649.
43. Zheng X, Wang Y, Wang Y. 2004. Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J. 23:1845-1856.
44. Zheng XD, Lee RT, Wang YM, Lin QS, Wang Y. 2007. Phosphorylation of Rga2, a Cdc42 GAP, by CDK/Hgc1 is crucial for Candida albicans hyphal growth. EMBO J. 26:3760-3769.
45. Shen J, Cowen LE, Griffin AM, Chan L, Kohler JR. 2008. The Candida albicans pescadillo homolog is required for normal hypha-to-yeast morphogenesis and yeast proliferation. Proc. Natl. Acad. Sci. U. S. A. 105: 20918-20923.
46. Reuss O, Vik A, Kolter R, Morschhauser J. 2004. The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341:119-127.
47. Guthrie C, Fink GR. 1991. Guide to yeast genetics and molecular biology. Academic Press, San Diego, CA.
48. Pierce CG, Uppuluri P, Tristan AR, Wormley FL, Jr, Mowat E, Ramage G, Lopez-Ribot JL. 2008. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat. Protoc. 3:1494-1500.
49. Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45:2475-2479.
50. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (ed). 1992. Current protocols in molecular biology. Greene Publishing Associates and Wiley-Interscience, New York, NY.
51. Dongari-Bagtzoglou A, Kashleva H. 2006. Development of a highly reproducible three-dimensional organotypic model of the oral mucosa. Nat. Protoc. 1:2012-2018.
52. Dongari-Bagtzoglou A, Kashleva H. 2006. Development of a novel threedimensional in vitro model of oral Candida infection. Microb. Pathog. 40:271-278.
53. Villar CC, Kashleva H, Mitchell AP, Dongari-Bagtzoglou A. 2005. Invasive phenotype of Candida albicans affects the host proinflammatory response to infection. Infect. Immun. 73:4588-4595.
54. Villar CC, Kashleva H, Nobile CJ, Mitchell AP, Dongari-Bagtzoglou A. 2007. Mucosal tissue invasion by Candida albicans is associated with Ecadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect. Immun. 75:2126-2135.
55. Nakayama H, Mio T, Nagahashi S, Kokado M, Arisawa M, Aoki Y. 2000. Tetracycline-regulatable system to tightly control gene expression in the pathogenic fungus Candida albicans. Infect. Immun. 68:6712-6719.
56. Blankenship JR, Fanning S, Hamaker JJ, Mitchell AP. 2010. An extensive circuitry for cell wall regulation in Candida albicans. PLoS Pathog. 6:e1000752. doi:10.1371/journal.ppat.1000752.
57. Goyard S, Knechtle P, Chauvel M, Mallet A, Prevost MC, Proux C, Coppee JY, Schwartz P, Dromer F, Park H, Filler SG, Janbon G, d'Enfert C. 2008. The Yak1 kinase is involved in the initiation and maintenance of hyphal growth in Candida albicans. Mol. Biol. Cell 19:2251-2266.
58. Kelly MT, MacCallum DM, Clancy SD, Odds FC, Brown AJ, Butler G. 2004. The Candida albicans CaACE2 gene affects morphogenesis, adherence and virulence. Mol. Microbiol. 53:969-983.
59. Kumamoto CA. 2005. A contact-activated kinase signals Candida albicans invasive growth and biofilm development. Proc. Natl. Acad. Sci. U. S. A. 102:5576-5581.
60. Ene IV, Bennett RJ. 2009. Hwp1 and related adhesins contribute to both mating and biofilm formation in Candida albicans. Eukaryot. Cell 8:1909-1913.
61. Nobile CJ, Nett JE, Andes DR, Mitchell AP. 2006. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot. Cell 5:1604-1610.
62. Nobile CJ, Andes DR, Nett JE, Smith FJ, Yue F, Phan QT, Edwards JE, Filler SG, Mitchell AP. 2006. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog. 2:e63. doi:10.1371/journal.ppat.0020063.
63. Braun BR, Kadosh D, Johnson AD. 2001. NRG1, a repressor of filamentous growth in C. albicans, is down-regulated during filament induction. EMBO J. 20:4753-4761.
64. Giusani AD, Vinces M, Kumamoto CA. 2002. Invasive filamentous growth of Candida albicans is promoted by Czf1p-dependent relief of Efg1p-mediated repression. Genetics 160:1749-1753.
65. Sohn K, Urban C, Brunner H, Rupp S. 2003. EFG1 is a major regulator of cell wall dynamics in Candida albicans as revealed byDNAmicroarrays. Mol. Microbiol. 47:89-102.
66. Carlisle PL, Kadosh D. 14 December 2012, posting date. A genomewide transcriptional analysis of morphology determination in Candida albicans. Mol. Biol. Cell [Epub ahead of print.] doi:10.1091/mbc.E12-01-0065.